NAD+ IV Therapy: What It Actually Does (And What It Doesn't)

The IV Drip Promising to Turn Back the Clock

Walk into any longevity clinic in Los Angeles, Miami, or Austin right now and you'll find people paying several hundred dollars to sit with a needle in their arm for four hours, getting a slow drip of a molecule their body already makes. NAD+ IV therapy has gone from obscure biohacker experiment to mainstream wellness offering in about five years flat. The before-and-after stories are everywhere: "I had more energy than I'd felt in a decade," "My brain fog lifted," "I finally slept through the night." People swear by it.

So what's actually happening in that drip bag? Is this a real clinical intervention with solid science behind it, or is it expensive placebo culture wearing a lab coat? The honest answer is: it's more real than most IV wellness trends, and less magical than the clinics selling it will tell you.

NAD+ IV therapy involves infusing nicotinamide adenine dinucleotide (NAD+), a coenzyme found in every cell of your body, directly into your bloodstream. The goal is to raise NAD+ levels that decline with age, address symptoms like fatigue and cognitive fog, and potentially support cellular repair processes linked to aging. Here's what the evidence actually says about whether it works, who it's right for, what it costs, and how it compares to cheaper alternatives like injections and oral supplements.

What Is NAD+ IV Therapy, Really?

NAD+ stands for nicotinamide adenine dinucleotide. It's a coenzyme, which means it's a helper molecule that enzymes need to do their jobs. Think of it as the spark plug for your cellular energy system. Without it, the hundreds of metabolic reactions your mitochondria run every second would simply stop.

Here's the origin story that makes NAD+ research interesting: scientists have known about this molecule since 1906, when Arthur Harden first identified it while studying yeast fermentation. But the longevity angle came much later, in the 2000s and 2010s, when researchers at MIT and Washington University showed that NAD+ levels drop by as much as 50% between the ages of 40 and 60, and that this decline is linked to mitochondrial dysfunction, impaired DNA repair, and many of the biological hallmarks of aging.

The IV version delivers NAD+ directly into the bloodstream, bypassing digestion entirely. That's the core argument for infusions over pills: when you swallow an NAD+ precursor, it has to survive your gut, get absorbed, travel to your cells, and be converted into NAD+. The IV route skips all of that. Whether that translates into meaningfully better outcomes for most people is a more complicated story.

How NAD+ IV Therapy Works

Your cells use NAD+ in two main contexts. First, as a shuttle molecule in the mitochondria, carrying electrons through the process that converts food into ATP (adenosine triphosphate, your body's actual energy currency). Second, as a substrate for proteins called sirtuins and PARP enzymes, which regulate DNA repair, gene expression, and inflammation responses. Both of these functions decline when NAD+ levels fall.

When you receive an IV infusion, NAD+ enters the bloodstream and is taken up by cells throughout the body. Inside cells, it's used directly or converted into related compounds. Research in Cell Metabolism has shown that IV NAD+ can raise plasma and intracellular NAD+ levels measurably within hours of infusion.

Here's the catch, though. Raising blood levels of NAD+ isn't the same thing as fixing the underlying reasons your levels were low. If your NAD+ is declining because of poor diet, sedentary behavior, or chronic inflammation, an infusion addresses the symptom, not the source. That's not an argument against using it, but it's context worth having before you spend the money.

The infusion is also notably slow. A full NAD+ IV typically runs between 500mg and 1,000mg and takes two to four hours, partly because pushing it in too fast causes an unpleasant constellation of side effects: chest tightness, nausea, a strange head-rushing sensation. This isn't dangerous at therapeutic doses, but it's also not something you schedule over a lunch break.

What the Evidence Actually Shows

The research on NAD+ IV therapy specifically is still relatively thin compared to the broader body of NAD+ biology research. Most of the compelling longevity data comes from animal studies or from trials using oral precursors like NMN and NR rather than direct infusions. That said, there are genuine signal points worth knowing.

Energy and fatigue

This is where the clinical signal is strongest. A 2020 study published in Frontiers in Neuroscience found that IV NAD+ infusions significantly improved fatigue, mood, and cognitive function in a group with complex fatigue conditions. Multiple smaller trials and case series in chronic fatigue syndrome (ME/CFS) populations show consistent subjective improvement in energy levels. The mechanism makes sense: if mitochondrial function is impaired and NAD+ is rate-limiting for ATP production, restoring it should help. How much it helps in otherwise healthy people with run-of-the-mill tiredness is less clear.

Cognitive function and brain fog

NAD+ is involved in neuronal energy metabolism and neuroprotection. Preclinical research shows NAD+ precursors can reduce neuroinflammation and support repair after injury. Human data specifically on IV NAD+ for cognition is limited, but anecdotal reports from clinicians are consistent enough to be noteworthy. This remains a "promising but not proven" area for cognitively healthy individuals.

Addiction and withdrawal support

This is actually one of the oldest clinical applications of IV NAD+. Practitioners have used high-dose NAD+ infusions to ease withdrawal symptoms from alcohol, opioids, and stimulants since the 1960s. A 2023 review in Substance Abuse and Rehabilitation found consistent evidence that NAD+ infusions reduced withdrawal severity and cravings, though the trials are mostly small and uncontrolled. The mechanism is thought to involve restoring depleted NAD+ in reward pathways.

Aging and cellular repair

The longevity angle is the most exciting and the most overstated. NAD+ is required by sirtuins, particularly SIRT1 and SIRT3, which are involved in DNA damage repair and mitochondrial quality control. Raising NAD+ in animal models produces impressive results: extended lifespan in yeast and worms, improved muscle function and metabolism in aged mice. You are not a mouse. Human trials on NAD+ repletion and aging biomarkers are ongoing, but we don't yet have strong human data showing IV NAD+ extends lifespan or meaningfully slows aging at the cellular level. What we have is a biologically plausible mechanism and early signals that warrant continued investigation.

Detoxification

This is where you should be skeptical. The idea that NAD+ IV therapy "detoxes" your body is mostly marketing language. NAD+ does support liver function (your liver uses it heavily in metabolizing alcohol and other compounds), and NAD+ depletion impairs the enzymes involved in detox pathways. But healthy people without liver stress or active substance use don't have meaningful detox backlogs that an NAD+ infusion will clear. If you're seeing language like "cellular detox" without specifics, that's usually a sign the clinic is filling space.

NAD+ IV vs. Injections vs. Oral Supplements: How Do They Compare?

This is the practical question most people actually want answered. Here's the honest breakdown:

• IV infusion: Highest bioavailability. Fastest effect. Most expensive ($300-$1,000+ per session). Takes 2-4 hours. Best evidence base for acute clinical uses (fatigue, withdrawal). Not practical as a weekly habit for most people.
• Intramuscular or subcutaneous injection: Better bioavailability than oral, faster than waiting for gut absorption. More practical than IV (takes minutes, not hours). Growing in popularity as a middle-ground option. Less studied than IV but the pharmacology is favorable.
• Oral precursors (NMN, NR): Most convenient, least expensive ($30-$80/month). Human trials show they do raise blood NAD+ levels measurably. A 2022 clinical trial in Nature Aging confirmed that oral NMN raises NAD+ in skeletal muscle in older adults. The question is whether that magnitude of increase translates into the same clinical effects as IV. Probably not for acute situations. Possibly sufficient for chronic maintenance.

The decision tree most clinicians use: if you have significant symptoms (severe fatigue, cognitive impairment, active withdrawal), IV gives you the fastest and most pronounced response. If you're relatively healthy and looking for maintenance and longevity support, oral precursors with occasional IV boosters is a reasonable and far more economical approach.

The Reality Check

The internet wants NAD+ IV therapy to be a fountain-of-youth treatment. The research is more nuanced than that.

Most of the human evidence is in people with significant NAD+ deficiency, whether from age-related decline, chronic illness, substance use, or metabolic disease. The effects are most pronounced in that population. For a healthy 35-year-old with decent energy levels and no cognitive complaints, a $600 NAD+ drip might produce a noticeable but temporary lift that fades within a week. That's not nothing, but it's also not transformation.

What we genuinely don't know yet: whether repeated NAD+ infusions produce cumulative, durable changes in aging biomarkers in humans. Whether there's a meaningful ceiling effect (more NAD+ stops helping past a certain point). What the optimal dosing frequency is for longevity versus symptom management. These are active research questions, not settled science.

One thing that is settled: IV NAD+ raises your NAD+ levels. The downstream effects of that are dose-, context-, and person-dependent.

Who Is NAD+ IV Therapy Actually Right For?

The people most likely to see real, noticeable benefit from NAD+ IV therapy tend to fall into a few categories:

• Adults over 45 with significant fatigue or brain fog that hasn't responded to basics like sleep, exercise, and diet optimization. These are the people whose NAD+ levels are most likely to be meaningfully low.
• People recovering from chronic illness, including long COVID, ME/CFS, or post-infectious fatigue syndromes, where mitochondrial dysfunction appears to play a role.
• Those in addiction recovery using NAD+ as part of a supervised protocol to ease withdrawal and rebuild neurochemical balance.
• High-performing adults in their 40s and 50s who have optimized the basics and are looking for additional metabolic support, particularly before or after major physical stressors.

NAD+ IV therapy is probably not your first move if you're under 40 with no particular symptoms, haven't addressed sleep, exercise, or diet, or are looking for a shortcut around fundamentals. The basics move the needle more for most people in that category. Get the foundation right first.

Risks and Side Effects

NAD+ IV therapy has a good safety profile overall, but it's not completely without discomfort or risk. Things to know going in:

• Infusion-rate side effects: Chest tightness, palpitations, nausea, flushing, and a strange "head rush" sensation are common if the drip runs too fast. These resolve when the rate is slowed. This is why rate control matters and why you want a clinically trained provider administering it.
• Headache and fatigue post-infusion: Some people feel tired or have a mild headache the day after their first infusion. This is generally transient and often resolves with subsequent sessions.
• IV-site discomfort: Minor bruising and soreness at the insertion site.
• Theoretical concerns in active cancer: Because NAD+ supports cellular energy metabolism generally, there's theoretical (not proven) concern about using it in the context of active malignancy. If you have or have had cancer, this is a conversation to have specifically with your oncologist.
• No serious adverse events have been reported in the clinical literature at standard therapeutic doses. This is not a high-risk intervention when administered correctly.

The case for clinical supervision isn't about preventing disaster; it's about getting dosing, rate, and frequency right so you actually get the benefit you're paying for.

How to Get Started with NAD+ at Healthspan

If you're thinking about NAD+ seriously rather than just picking up the cheapest NMN capsules on Amazon, the Longevity Optimization program at Healthspan is a reasonable starting point. It's a clinically supervised protocol that begins with comprehensive lab work to actually assess where your NAD+ levels, mitochondrial function markers, and metabolic health stand before recommending anything.

That matters more than it sounds. NAD+ therapy without baseline labs is a bit like refilling a gas tank you haven't checked. You might need it urgently or you might be topping off something that was already fine. Knowing where you actually start lets you and your clinician set a rational protocol: what form of NAD+ makes sense for you (IV, injection, oral precursor), at what dose, and how often to reassess.

The protocol includes physician consultations, ongoing monitoring, and adjustments based on how you respond. This isn't a supplement you order and self-experiment with. It's a supervised clinical process where the goal is measurable, trackable change in your biology, not just a good anecdote to share at a dinner party.

If you want to understand your full metabolic and longevity picture before deciding whether NAD+ is even the right lever for you, the Longevity Pro Panel gives you a comprehensive biomarker baseline, including mitochondrial function, inflammation markers, and metabolic health indicators that tell a complete story about where your biology actually is.

Start with the data. Then make the protocol decision.

Frequently Asked Questions About NAD+ IV Therapy

How long does an NAD+ IV infusion take?

A standard NAD+ IV infusion typically takes between two and four hours, depending on the dose (usually 500mg to 1,000mg) and your tolerance for the infusion rate. It can't be rushed significantly without causing unpleasant side effects like chest tightness, nausea, and flushing. Plan to block out a half-day if you're doing a full-dose infusion.

How often should you get NAD+ IV therapy?

There's no universally agreed-upon protocol. For symptom management or initial repletion, many clinicians start with a loading phase of two to five infusions over one to two weeks. For ongoing maintenance, once monthly to once every few months is common. Frequency should be guided by your baseline levels, symptoms, and response to initial infusions, which is why clinical oversight matters.

Is NAD+ IV therapy better than oral NMN or NR supplements?

For acute symptom relief and fastest effect, IV delivers more NAD+ faster and more reliably. For long-term maintenance in otherwise healthy adults, oral precursors like NMN or NR have been shown in clinical trials to raise blood NAD+ levels meaningfully and are far more economical. IV is the better choice for clinical applications; oral is often sufficient for general longevity support.

How much does NAD+ IV therapy cost?

Costs vary widely by provider and location, ranging from roughly $300 to over $1,000 per infusion. A loading series of multiple infusions can run $1,500 to $4,000. This is generally not covered by insurance. Comparing this to oral NMN/NR supplements at $30-$80 per month, the cost difference is substantial, which is why understanding whether you actually need IV-level delivery matters.

What does NAD+ IV therapy feel like?

Most people report feeling a mild warmth, slight chest pressure, or tingling during the infusion if the rate is even slightly fast. At the correct rate, it's mostly just sitting with an IV in your arm for a couple of hours. Post-infusion, many people report feeling more alert and energized within hours. A minority feel fatigued the day after their first session, which typically resolves with subsequent infusions.

Can NAD+ IV therapy help with long COVID or chronic fatigue?

This is one of the more evidence-supported use cases. Mitochondrial dysfunction and impaired NAD+ metabolism appear to contribute to the fatigue and cognitive symptoms in both ME/CFS and long COVID. Several small clinical studies and case series show meaningful symptom improvement with NAD+ infusions in these populations. It's not a guaranteed fix, but the biological rationale is solid and the early data is encouraging.

Is NAD+ IV therapy safe?

At standard therapeutic doses administered by trained providers, NAD+ IV therapy has a good safety profile. The main risks are infusion-rate-related discomfort (chest tightness, nausea, flushing) that resolves when the drip is slowed, and minor IV-site soreness. No serious adverse events have been reported in the clinical literature at therapeutic doses. People with active cancer should consult an oncologist before use due to theoretical concerns about cellular energy support.